Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: poodle who wrote (794)	1/17/1998 12:43:00 PM
From: Jeff Briley	Read Replies (1) \| Respond to of 3576

I think this is a big one, guys. Look at the price levels of some of the Biotech companies out there now just based on a "promising" outlook. This company could change the world drastically and they have tight patents on their technology. I usually trade short term, but after watching the 20/20 Special on GERN last night, I'm sacking my 1000 shares away for a while and actually will be trying to pick up more next week. I expect GERN to break out to a new all-time high next week (probably on Tuesday because of the buying along with the short squeeze we're gonna get right from the start), and continue its climb from there. I think $40 or higher is very possible short-term considering the potential here. Sure, their "anti-aging pill" may not be available for 5-10 years, but if you were a fund manager, wouldn't this stock look attractive as a long-term hold?? Best of luck to all... Jeff